2025 annual financial data
Capricor Therapeutics 2025 Operating margin
Capricor Therapeutics 2025 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -108,142,130 USD and net income was -105,043,946 USD.
Operating cash flow was -69,811,261 USD.
Get free Capricor Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -108,142,130 USD
- Net income
- -105,043,946 USD
- Operating cash flow
- -69,811,261 USD